AccuReg Revenue and Competitors

Mobile, AL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AccuReg's estimated annual revenue is currently $82M per year.(i)
  • AccuReg's estimated revenue per employee is $297,000

Employee Data

  • AccuReg has 276 Employees.(i)

AccuReg's People

NameTitleEmail/Phone
1
OwnerReveal Email/Phone
2
Senior Program Manager & Chief StaffReveal Email/Phone
3
VP Product Management at AccuReg | Patient Access, Digital Patient Engagement & IntakeReveal Email/Phone
4
VP Client ServicesReveal Email/Phone
5
VP Product DevelopmentReveal Email/Phone
6
Chief Growth OfficerReveal Email/Phone
7
Chief Product Officer and Chief Information Officer(acquired by United Health Group)Reveal Email/Phone
8
Director Data ScienceReveal Email/Phone
9
Executive Director Registration ServicesReveal Email/Phone
10
Director Strategic GrowthReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.3M37N/AN/AN/A
#2
$17.9M138N/AN/AN/A
#3
$66.5M224N/AN/AN/A
#4
$4.3M23N/AN/AN/A
#5
$130.1M0N/A$96.2MN/A
#6
$12.6M0N/A$37.8MN/A
Add Company

What Is AccuReg?

keywords:N/A

N/A

Total Funding

276

Number of Employees

$82M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

AccuReg News

2022-04-17 - Value-Based Reimbursement Software Market 2022 | Covid19 ...

iClinic, HealthQx, Quadax, 3M Codefinder, AccuReg, ActiveASSIST, Apex Connect, Aver Operationalize, ClearGage, Edifecs Value-Based Care,...

2022-04-17 - Tearing Down the Barrier of Prior Authorization Through ...

Paul Shorrosh, founder and CEO of AccuReg is here to change that. Shorrosh sits down with host Kevin Stevenson to talk about the importance...

2022-04-17 - Patient Access Solutions Market 2022 Industry Opportunities ...

AccuReg Software, Cerner Corporation, Cirius Group, Inc., Cognizant, Conifer Health Solutions, LLC, Craneware, Inc., Epic Systems,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$97.9M3459%N/A
#2
$143.9M351-2%N/A
#3
$30.5M3749%N/A
#4
$123.5M3893%N/A
#5
N/A429-6%N/A